Symbiomix Therapeutics Company
Symbiomix Therapeutics is a privately-held biopharmaceutical company that offers anti-infective drug and single dose treatment.
%20.jpg)
Total Funding:
$47 000 000
Headquarters:
Newark, New Jersey, United States
Funding Status:
M&A
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Last Funding Type:
Venture - Series Unknown
Number Of Exists:
Venture - Series Unknown
Technology:
Cancer
Investor Type:
Company
Last Funding Date:
2018-01-01
Investors Number:
5
Founded Date:
2012
Industry:
PharmTech